Fig. 7

The efficacy of 7CZ nanomedicines in rats with ADR-induced nephrotic syndrome. a Schematic illustration for establishing nephrotic syndrome model and their treatment with 7CZ nanomedicines. b Changes in body weight were recorded in 8 days of post treatment. c The ratio of urine protein to creatinine after 8-day treatment. d Quantitative analysis of the foot process width by Image J. e PAS staining of the kidney after various treatments. f TEM of the morphology in podocytes was observed after different treatments. Data are presented as mean ± SD, one-way ANOVA, ns, non-significance, *P < 0.05, **P < 0.01; ***P < 0.001, ****P < 0.0001, vs. ADR group